Between the high cost of insulin and other supplies, affording the necessary treatments to survive as a diabetic can be incredibly costly.
New Report Debunks Pharma's Claim That Any Restraint On Its Unilateral Pricing Power Will Destroy Innovation And Access To New Medicines.
Can we constrain drug corporations’ unfettered pricing power in the United States and still get the innovation we seek?
Our family has done our duty for our country only to see the system let us down in our time of need.
Veteran Advocacy Leader Sheila McLean Takes The Helm At Critical Moment For Drug Pricing Reform.